
                         Roanoke Times
                 Copyright (c) 1995, Landmark Communications, Inc.

DATE: TUESDAY, September 21, 1993                   TAG: 9309210157
SECTION: NATIONAL/INTERNATIONAL                    PAGE: A2   EDITION: NEW RIVER VALLEY 
SOURCE: 
DATELINE: ROCKVILLE, MD.                                LENGTH: Short

PANEL RECOMMENDS OK FOR AIDS TREATMENT DRUG

A Food and Drug Administration advisory committee voted Monday to recommend approval of ddC as a single-drug therapy against AIDS.

The drug, marketed under the brand name HIVID by Hoffmann-LaRoche Inc., of Nutley, N.J., had been approved previously used in combination with another AIDS drug.

The committee vote is only a recommendation and final action will have to be taken by the FDA. The agency usually follows the advice of its advisory committees.

The committee also voted to remove HIVID from a conditional approval under which it had been authorized for use in combination with AZT, or zidovudine. It now would get full approval.

If the FDA follows the committee recommendation, HIVID will become the third drug approved for single-drug therapy against AIDS. The others are AZT and ddI, or didanonsine - Associated Press

Memo: shorter version ran in the Metro edition.

by CNB